Back
Petros Pharmaceuticals Stock Price Chart
Sponsored
PTPI
Sponsored
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
37
PTPI
Petros Pharmaceuticals
Last Price:
0.35
Seasonality Move:
8.08%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTPI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Petros Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.36 | Sell |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 0.82 | Sell |
8-day EMA: | 0.35 | Buy |
20-day EMA: | 0.35 | Buy |
50-day EMA: | 0.38 | Sell |
200-day EMA: | 0.88 | Sell |
Petros Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.82 | Sell |
Chaikin Money Flow: | -11978 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.33 - 0.37) | Buy |
Bollinger Bands (100): | (0.33 - 0.51) | Sell |
Petros Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Petros Pharmaceuticals Stock
Is Petros Pharmaceuticals Stock a Buy?
- Petros Pharmaceuticals share price is 0.36 while PTPI 8-day simple moving average is 0.35, which is a Buy signal.
- The stock price of PTPI is 0.36 while Petros Pharmaceuticals 20-day SMA is 0.36, which makes it a Sell.
- Petros Pharmaceuticals 50-day simple moving average is 0.36 while PTPI share price is 0.36, making it a Sell technically.
- PTPI stock price is 0.36 and Petros Pharmaceuticals 200-day simple moving average is 0.82, creating a Sell signal.
PTPI Technical Analysis vs Fundamental Analysis
Sell
37
Petros Pharmaceuticals (PTPI)
is a Sell
Is Petros Pharmaceuticals a Buy or a Sell?
-
Petros Pharmaceuticals stock is rated a Sell
The current Petros Pharmaceuticals [PTPI] share price is $0.36. The Score for PTPI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Petros Pharmaceuticals Stock Info
Market Cap:
3.41M
Price in USD:
0.36
Share Volume:
39.36K
Petros Pharmaceuticals 52-Week Range
52-Week High:
2.27
52-Week Low:
0.28
Sell
37
Petros Pharmaceuticals (PTPI)
is a Sell
Petros Pharmaceuticals Share Price Forecast
-
What is the Petros Pharmaceuticals stock price today?
The Petros Pharmaceuticals stock price is 0.36 USD today. -
Will PTPI stock go up or go down?
Petros Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Petros Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Petros Pharmaceuticals is overvalued.
Is Petros Pharmaceuticals Stock a Buy?
- Petros Pharmaceuticals share price is 0.36 while PTPI 8-day exponential moving average is 0.35, which is a Buy signal.
- The stock price of PTPI is 0.36 while Petros Pharmaceuticals 20-day EMA is 0.35, which makes it a Buy.
- Petros Pharmaceuticals 50-day exponential moving average is 0.38 while PTPI share price is 0.36, making it a Sell technically.
- PTPI stock price is 0.36 and Petros Pharmaceuticals 200-day simple moving average is 0.88, creating a Sell signal.
Fundamental Analysis of Petros Pharmaceuticals
Is Petros Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.04 per share.
Technical Analysis of Petros Pharmaceuticals
Should I short Petros Pharmaceuticals stock?
- PTPI Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Petros Pharmaceuticals is a Sell
- Petros Pharmaceuticals Relative Strength Index (RSI) is 49.82, which suggest Petros Pharmaceuticals is oversold
- The Bollinger Bands (25) for Petros Pharmaceuticals is (0.33 - 0.37), which suggest Petros Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Petros Pharmaceuticals is (0.33 - 0.51), which suggest Petros Pharmaceuticals is a Sell
* Petros Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.